Compile Data Set for Download or QSAR
maximum 50k data
Found 576 with Last Name = 'casarez' and Initial = 'a'
TargetGenome polyprotein [1027-1657](Hepatitis C virus genotype 1a (isolate 1) (HCV))
Gilead Sciences

US Patent
LigandPNGBDBM97753(US8476225, 14)
Affinity DataIC50:  2nMpH: 7.5 T: 2°CAssay Description:Inhibition assay using HCV protease.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein [1027-1657](Hepatitis C virus genotype 1a (isolate 1) (HCV))
Gilead Sciences

US Patent
LigandPNGBDBM97758(US8476225, 19)
Affinity DataIC50:  2nMpH: 7.5 T: 2°CAssay Description:Inhibition assay using HCV protease.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein [1027-1657](Hepatitis C virus genotype 1a (isolate 1) (HCV))
Gilead Sciences

US Patent
LigandPNGBDBM97799(US8476225, 60)
Affinity DataIC50:  2nMpH: 7.5 T: 2°CAssay Description:Inhibition assay using HCV protease.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein [1027-1657](Hepatitis C virus genotype 1a (isolate 1) (HCV))
Gilead Sciences

US Patent
LigandPNGBDBM97773(US8476225, 34)
Affinity DataIC50:  2nMpH: 7.5 T: 2°CAssay Description:Inhibition assay using HCV protease.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein [1027-1657](Hepatitis C virus genotype 1a (isolate 1) (HCV))
Gilead Sciences

US Patent
LigandPNGBDBM97798(US8476225, 59)
Affinity DataIC50:  2nMpH: 7.5 T: 2°CAssay Description:Inhibition assay using HCV protease.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein [1027-1657](Hepatitis C virus genotype 1a (isolate 1) (HCV))
Gilead Sciences

US Patent
LigandPNGBDBM97761(US8476225, 22)
Affinity DataIC50:  2nMpH: 7.5 T: 2°CAssay Description:Inhibition assay using HCV protease.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein [1027-1657](Hepatitis C virus genotype 1a (isolate 1) (HCV))
Gilead Sciences

US Patent
LigandPNGBDBM97789(US8476225, 50)
Affinity DataIC50:  3nMpH: 7.5 T: 2°CAssay Description:Inhibition assay using HCV protease.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein [1027-1657](Hepatitis C virus genotype 1a (isolate 1) (HCV))
Gilead Sciences

US Patent
LigandPNGBDBM97763(US8476225, 24)
Affinity DataIC50:  3nMpH: 7.5 T: 2°CAssay Description:Inhibition assay using HCV protease.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein [1027-1657](Hepatitis C virus genotype 1a (isolate 1) (HCV))
Gilead Sciences

US Patent
LigandPNGBDBM97760(US8476225, 21)
Affinity DataIC50:  4nMpH: 7.5 T: 2°CAssay Description:Inhibition assay using HCV protease.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein [1027-1657](Hepatitis C virus genotype 1a (isolate 1) (HCV))
Gilead Sciences

US Patent
LigandPNGBDBM97749(US8476225, 10)
Affinity DataIC50:  4nMpH: 7.5 T: 2°CAssay Description:Inhibition assay using HCV protease.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein [1027-1657](Hepatitis C virus genotype 1a (isolate 1) (HCV))
Gilead Sciences

US Patent
LigandPNGBDBM97746(US8476225, 7)
Affinity DataIC50:  5nMpH: 7.5 T: 2°CAssay Description:Inhibition assay using HCV protease.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein [1027-1657](Hepatitis C virus genotype 1a (isolate 1) (HCV))
Gilead Sciences

US Patent
LigandPNGBDBM97797(US8476225, 58)
Affinity DataIC50:  5nMpH: 7.5 T: 2°CAssay Description:Inhibition assay using HCV protease.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein [1027-1657](Hepatitis C virus genotype 1a (isolate 1) (HCV))
Gilead Sciences

US Patent
LigandPNGBDBM97777(US8476225, 38)
Affinity DataIC50:  5nMpH: 7.5 T: 2°CAssay Description:Inhibition assay using HCV protease.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein [1027-1657](Hepatitis C virus genotype 1a (isolate 1) (HCV))
Gilead Sciences

US Patent
LigandPNGBDBM97762(US8476225, 23)
Affinity DataIC50:  6nMpH: 7.5 T: 2°CAssay Description:Inhibition assay using HCV protease.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein [1027-1657](Hepatitis C virus genotype 1a (isolate 1) (HCV))
Gilead Sciences

US Patent
LigandPNGBDBM97759(US8476225, 20)
Affinity DataIC50:  6nMpH: 7.5 T: 2°CAssay Description:Inhibition assay using HCV protease.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein [1027-1657](Hepatitis C virus genotype 1a (isolate 1) (HCV))
Gilead Sciences

US Patent
LigandPNGBDBM97772(US8476225, 33)
Affinity DataIC50:  9nMpH: 7.5 T: 2°CAssay Description:Inhibition assay using HCV protease.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGenome polyprotein [1027-1657](Hepatitis C virus genotype 1a (isolate 1) (HCV))
Gilead Sciences

US Patent
LigandPNGBDBM97770(US8476225, 31)
Affinity DataIC50:  9nMpH: 7.5 T: 2°CAssay Description:Inhibition assay using HCV protease.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Gossamer Bio Services

US Patent
LigandPNGBDBM615878(US20230271954, Compound 177 | cis-8-((4-(((1,4-dio...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Gossamer Bio Services

US Patent
LigandPNGBDBM615753(US20230271954, Compound 52 | cis-8-((-4-((4-fluoro...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Gossamer Bio Services

US Patent
LigandPNGBDBM615902(US20230271954, Compound 201 | cis-8-((-4-((4-fluor...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase alpha(Homo sapiens)
Gossamer Bio Services

US Patent
LigandPNGBDBM615883(US20230271954, Compound 182 | cis-8-((4-(((1,4-dio...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Gossamer Bio Services

US Patent
LigandPNGBDBM615904(US20230271954, Compound 203 | cis-8-((-4-(((1,4-di...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Gossamer Bio Services

US Patent
LigandPNGBDBM615800(US20230271954, Compound 99 | cis-8-4-((cyclobutylm...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Gossamer Bio Services

US Patent
LigandPNGBDBM615801(US20230271954, Compound 100 | cis-8-4-((cyclobutyl...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Gossamer Bio Services

US Patent
LigandPNGBDBM615769(US20230271954, Compound 68 | cis-8-4-((4-fluorophe...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Gossamer Bio Services

US Patent
LigandPNGBDBM615803(US20230271954, Compound 102 | cis-8-4-((cyclopropy...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Gossamer Bio Services

US Patent
LigandPNGBDBM615833(US20230271954, Compound 132 | trans-4-((-4-(benzo[...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Gossamer Bio Services

US Patent
LigandPNGBDBM615672(US20230271954, Compound 3A | trans-6-chloro-4-((4-...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Gossamer Bio Services

US Patent
LigandPNGBDBM615673(US20230271954, Compound 3B | trans-6-chloro-4-((4-...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Gossamer Bio Services

US Patent
LigandPNGBDBM615861(US20230271954, Compound 160 | cis-8-((-4-((cyclobu...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Gossamer Bio Services

US Patent
LigandPNGBDBM615862(US20230271954, Compound 161 | cis-8-((-4-((cyclobu...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Gossamer Bio Services

US Patent
LigandPNGBDBM615864(US20230271954, Compound 163 | cis-8-((-4-(((1,4-di...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Gossamer Bio Services

US Patent
LigandPNGBDBM615844(US20230271954, Compound 143 | cis-8-((-4-(benzo[d]...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Gossamer Bio Services

US Patent
LigandPNGBDBM615756(US20230271954, Compound 55 | cis-8-((4-((4-fluorop...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Gossamer Bio Services

US Patent
LigandPNGBDBM615758(US20230271954, Compound 57 | US20230271954, Compou...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Gossamer Bio Services

US Patent
LigandPNGBDBM615736(US20230271954, Compound 35 | cis-8-((4-((4-chlorop...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Gossamer Bio Services

US Patent
LigandPNGBDBM615786(US20230271954, Compound 85 | trans-6-chloro-4-4-((...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Gossamer Bio Services

US Patent
LigandPNGBDBM615817(US20230271954, Compound 116 | cis-8-((-4-(benzo[d]...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Gossamer Bio Services

US Patent
LigandPNGBDBM615711(US20230271954, Compound 10 | cis-6-chloro-4-((4-(c...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Gossamer Bio Services

US Patent
LigandPNGBDBM615792(US20230271954, Compound 91 | cis-8-4-((cyclobutylm...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Gossamer Bio Services

US Patent
LigandPNGBDBM615717(US20230271954, Compound 16 | cis-6-chloro-4-((4-(c...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Gossamer Bio Services

US Patent
LigandPNGBDBM615743(US20230271954, Compound 42 | cis-8-((-4-((cyclobut...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Gossamer Bio Services

US Patent
LigandPNGBDBM615764(Cis-8-4-((cyclopropylmethyl)(3,4-difluorophenyl) a...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Gossamer Bio Services

US Patent
LigandPNGBDBM615744(US20230271954, Compound 43 | cis-8-((-4-((cyclobut...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Gossamer Bio Services

US Patent
LigandPNGBDBM615797(US20230271954, Compound 96 | trans-6-chloro-4-((cy...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Gossamer Bio Services

US Patent
LigandPNGBDBM615798(US20230271954, Compound 97 | cis-8-4-(benzo[d][1,3...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein [1027-1657](Hepatitis C virus genotype 1a (isolate 1) (HCV))
Gilead Sciences

US Patent
LigandPNGBDBM97771(US8476225, 32)
Affinity DataIC50:  10nMpH: 7.5 T: 2°CAssay Description:Inhibition assay using HCV protease.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Gossamer Bio Services

US Patent
LigandPNGBDBM615750(US20230271954, Compound 49 | cis-8-((4-(cyclopropy...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Gossamer Bio Services

US Patent
LigandPNGBDBM615751(US20230271954, Compound 50 | cis-8-((4-(cyclopropy...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDiacylglycerol kinase zeta(Homo sapiens)
Gossamer Bio Services

US Patent
LigandPNGBDBM615752(US20230271954, Compound 51 | cis-6-chloro-4-((4-(c...)
Affinity DataIC50: <10nMAssay Description:Compounds of the present invention were prepared into 10 mM DMSO solution and 10 nL of stock was transferred into 384 plates (Optiplate 384 plate) us...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 576 total ) | Next | Last >>
Jump to: